BioRestorative Therapies, Inc. (BRTX): Revenue
$359.7K
Year ended 2025-12-31
$357.9K
Trailing 12 months to 2026-03-31
+44.3%
3-year compound annual growth
+36.1%
5-year compound annual growth
-5.4%
10-year compound annual growth
| Period ended | Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $359.7K | -10.3% | 2026-03-26, From 2025-01-01 |
| 2024-12-31 | $401.0K | +175.0% | 2026-03-26, From 2024-01-01 |
| 2023-12-31 | $145.8K | +21.7% | 2025-03-28, From 2023-01-01 |
| 2022-12-31 | $119.8K | +160.4% | 2024-06-11, From 2022-01-01 |
| 2021-12-31 | $46.0K | -40.3% | 2023-03-27, From 2021-01-01 |
| 2020-12-31 | $77.0K | -40.8% | 2022-03-30, From 2020-01-01 |
| 2019-12-31 | $130.0K | +17.1% | 2021-04-30, From 2019-01-01 |
| 2018-12-31 | $111.0K | +37.0% | 2021-03-18, From 2018-01-01 |
| 2017-12-31 | $81.0K | +122.8% | 2019-03-29, From 2017-01-01 |
| 2016-12-31 | $36.4K | -94.2% | 2018-04-02, From 2016-01-01 |
| 2015-12-31 | $628.9K | +51.2% | 2017-03-22, From 2015-01-01 |
| 2014-12-31 | $416.0K | n/m | 2016-03-30, From 2014-01-01 |
| 2013-12-31 | $1.7K | -89.2% | 2015-03-31, From 2013-01-01 |
| 2012-12-31 | $15.6K | n/a | 2014-04-11, From 2012-01-01 |
| 2011-12-31 | $0 | n/a | 2013-04-02, From 2011-01-01 |
Revenue at similar companies
| Company | Year ended | Revenue | Change YoY |
|---|---|---|---|
| BioRestorative Therapies, Inc. (BRTX) | 2025-12-31 | $359.7K | -10.3% |
| Mangoceuticals, Inc. (MGRX) | 2025-12-31 | $456.0K | -26.0% |
| Charming Medical Ltd (MCTA) | 2026-03-31 | $4.81M | -22.7% |
| Pacific Health Care Organization Inc (PFHO) | 2025-12-31 | $6.72M | +10.7% |
| Marpai, Inc. (MRAI) | 2025-12-31 | $18.10M | -35.8% |
| Cryo Cell International Inc (CCEL) | 2025-11-30 | $31.57M | -1.3% |
| Viemed Healthcare, Inc. (VMD) | 2025-12-31 | $270.28M | +20.5% |
| Sotera Health Co (SHC) | 2025-12-31 | $1.16B | +5.7% |
| Progyny, Inc. (PGNY) | 2025-12-31 | $1.29B | +10.4% |
Compare BRTX, MGRX, MCTA, PFHO side by side · Screen every company in Services-Misc Health & Allied Services, NEC ↗